Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Jan 29, 2010

Premium

Thermo Fisher Scientific launched its new line of Thermo Scientific Staudinger Ligation Reagents for the in vitro and in vivo labeling of biomolecules.

In a statement, Thermo Fisher said that the Staudinger chemistry relies on azide-phosphine conjugation that works well in live-cell labeling and mass spectrometry applications. The reagents work especially well for the study of protein glycosylation, it added.


Caprotec Bioanalytics this week launched three new caproKits for the discovery, identification, and characterization of proteins belonging to the groups of metallo-proteases, histon-deacetylases, and GDP/GTP binding proteins.

The new kits are Marimastat caproKit, SAHA caproKit, and GDP caproKit, bringing the total number of caproKits to seven. The new kits target research into signal transduction, epigenetics, and proteases.

All the caproKits are based on the company's Capture Compound Mass Spectrometry technology for investigating small molecule-protein interactions. The CCMS platform is based on tri-functional molecules called capture compounds that allow for the isolation of proteins and protein classes directly from complex biological samples.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.